Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Sor-c13 TFA | 1187852-48-7 | 99.3% | 1565.81 | 25 MG
Supplier: Medchemexpress LLC 25MGHYP1651A
SOR-C13 TFA is a carboxy-terminal truncated peptide. It functions as a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel associated with malignancy and poor prognosis in breast cancer. SOR-C13 TFA exhibits anticancer activity.
- High-affinity TRPV6 antagonist with an IC50 value of 14 nM.
- Associated with malignancy and poor prognosis in breast cancer.
- Exhibits anticancer activity.
- For research use only.
- Not for sale to patients.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?